Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLD-BCD for Multiple Myeloma
NCT00849251Phase 2Terminated
- Sponsor
- University of Washington
- Start
- Nov 2008
- Primary completion
- Dec 2011
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of pegylated liposomal doxorubicin in multiple myeloma (MM), sponsored by University of Washington. Started Nov 2008; status: terminated.
02
Drugs
pegylated liposomal doxorubicin
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00849251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00849251.